Retrospective Cohort Study of Intracerebral Hemorrhage

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators design a retrospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective, treatments and prognosis of Chinese hospitalized adult patients with intracerebral hemorrhage.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Cohort Study of Intracerebral Hemorrhage

NCT04707105

Intracerebral Hemorrhage

RECRUITING

Clinical Outcomes Following Primary Intracerebral Hemorrhage

NCT06548737

Stroke Intracerebral Hemorrhage

RECRUITING

A Cohort Study of Patients With Intracranial Hemorrhage

NCT05760950

Intracerebral Hemorrhage

UNKNOWN

Prospective Cohort of Patients With Intracerebral Hemorrhage

NCT06670456

Stroke, Acute Intracerebral Hemorrhage

RECRUITING

Chongqing Intracerebral Hemorrhage Study

NCT03085472

Intracerebral Hemorrhage Stroke Hematoma

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intracerebral hemorrhage (ICH) remains a devastating disease with high mortality, yet few therapeutic managements have been proved effective. Large quantities of work needs to be done to fully delineate the prevalence and prognosis of ICH. Hence, the investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective, treatments and prognosis of Chinese hospitalised adult patients with ICH.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracerebral Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Second Affiliated Hospital, School of Medicine, Zhejiang University

a prospective cohort of patients of primary intracerebral hemorrhage in Second Affiliated Hospital, School of Medicine, Zhejiang University

No interventions assigned to this group

Second People's Hospital of Hangzhou City, Zhejiang Province

a prospective cohort of patients of primary intracerebral hemorrhage in Second People's Hospital of Hangzhou City, Zhejiang Province

No interventions assigned to this group

4th Affiliated Hospital, School of Medicine at Zhejiang University

a prospective cohort of patients of primary intracerebral hemorrhage in 4th Affiliated Hospital, School of Medicine at Zhejiang University

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalized patients over 18 years old of primary intracerebral hemorrhage.

Exclusion Criteria

1. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor
2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients
3. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
4. patients cannot be followed up for any reasons.
5. patients death in 24 hours
6. pregnant patients
7. surgical evacuation of hematoma

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No